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This paper introduces an important area of computational cell biology where complex, 
publicly available genomic data is being examined by linear algebra methods, with 
the aim of revealing biological and medical insights. 
 
Section 1: What’s New? 
Since the time of Gregor Mendel, biologists have been attempting to understand how 
genes determine biological properties.  Differences in genes largely explain biological 
diversity. But in spite of this all humans are recognisably the same due to our control 
systems that respond to driving forces such as feeding, stress, infection, age, sex and 
environment.  These controls operate at all possible levels, many of which can now be 
studied using high-throughput technology. Microarrays observe the transfer of 
information from deoxyribonucleic acid (DNA), containing around 30,000 genes, to 
messenger ribonucleic acid (mRNA).  In this way the state of all these genes can be 
recorded for individual samples.  In terms of the functioning of the cell, genes are 
important because the mRNA that they create goes on to produce proteins, and 
proteins are the catalysts of all cells activities. Maybe 20,000 mRNA signals are 
responsible for the production of proteins in any single human cell and it is thought 
that major aspects of development, and disease, can be understood at the gene-
mRNA-protein level.  
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Defects in genes (mutations) can contribute to particular diseases, like cancers, but it 
is unusual for a single mutation to be found in all cases of one type of cancer.  For 
instance the cancer drug Herceptin, recently in the news, is only affective for the 20% 
of women with breast cancer who overproduce the protein Her-2.  Generally, there are 
two main reasons to subdivide patients into subgroups based on mRNA profiles: first 
the groups may respond differently to treatment and second biologists want insight 
into the disease process. 
 
The challenge of making sense of complex genomic information, often involving 
many genes over relatively few samples, provides many opportunities for 
mathematicians. Typical data sets take the familiar form of matrices: two dimensional 
arrays. It is the size of the matrices (at least one dimension in the thousands or 
hundreds of thousands), the level of uncertainty in the measurements (repeating 
experiments to a degree that classical statistical tests are passed is often prohibitively 
expensive) and the imprecise nature of the questions to be addressed, that present the 
main challenges to applied and computational mathematicians.  
 
Basic biology [Elliot&Elliot03] teaches us that DNA forms an organisms genetic 
signature - arranged as 24 one-dimensional lattices (chromosomes).  Analogously, 
mathematicians know that the singular value decomposition (SVD) of a matrix forms 
a spectral signature, encoding many of its fundamental properties 
[Golub&VanLoan96]. It is not surprising, therefore, that the SVD is proving to be a 
valuable tool for teasing meaningful information out of large biological data sets. 
 
Our aim in this article is to give an introductory account of (a) where this type of 
genomic data comes from and (b) how the SVD can be used to add value. Very little 
biological and mathematical background is assumed, and the SVD is seen to arise 
naturally from an algorithmic perspective. Because of its relevance and timeliness, we 
see this material as ideal for incorporating into undergraduate courses on linear 
algebra, scientific computing or mathematical biology, or for the basis of an 
independent study project. References to accessible texts in biology are included in 
subsequent sections for those who wish to learn more. 
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Section 2: What is the Data?   
DNA may be viewed as a linear string where each character is one of the four 
nucleotide bases (C,A,T,G). The string is arranged into a regular double-helix 
structure. Certain contiguous chunks of DNA, that satisfy known constraints, can code 
for genes. Genes are important because they code for proteins. Proteins are linear 
strings of amino acids, from an alphabet of 20 characters, but, unlike DNA, these 
strings fold into complicated 3D shapes, capable of interacting with each other in a 
myriad of ways. The Central Dogma of Molecular Biology states that a DNA gene 
specifies its unique mRNA, which in turn specifies its unique protein (Figure 1). This 
is an oversimplified picture, but it allows useful conclusions to be drawn. There are 
many references available for those who wish to learn more about basic cell biology 
from a mathematics/informatics perspective; including [Brazma, Kanehisa03]. We 
will be concerned with two types of data that give glimpses into the workings of the 
cell. Microarrays are used to estimate simultaneously the amount of each mRNA that 
is present, so it is now possible to have this information for many thousands of genes 
in every experiment. At a higher level, protein-protein interaction (PPI) data 
measures which pairs of proteins appear to bind physically, thereby giving clues about 
the proteins biological functions.   
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Figure 1: The Central Dogma of Molecular Biology states that a DNA gene specifies 
its unique mRNA, which in turn specifies its unique protein.
If one gene is responsible for creating one mRNA and hence one type of protein, then 
each microarray experiment records the activity of each individual gene. This data can 
be represented by a one-dimensional vector whose ith entry stores the expression level 
of the ith gene. Typically, data from several experiments will be collected. For 
example, tissue from different cancer patients may be tested, or a single tissue may be 
tested at different times in order to produce a time series. In both cases, the different 
experiments are usually referred to as samples, and the resulting data set can be 
thought of as a two-dimensional array, with the jth column representing the one-
dimensional output for the jth sample. These mRNA measurements are often called 
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gene-expression data and they give a snapshot of the state of transcription of each 
sample, which in turn reflects the relative importance of their proteins in that tissue.  
Some leukaemia patients, for example, overproduce Red Blood Cell (RBC) mRNA 
and proteins including haemoglobin  responsible for the red colour of blood and 
oxygen transport.  In addition to haemoglobin about 40 other RBC genes are 
switched-on at the same time.  These proteins are all involved in the architectural 
and biochemical makeup of RBCs which deliver oxygen from the lungs with every 
breath and get rid of carbon dioxide at the same time.  On the other hand, the normal 
genes for lung function, including the surfactant protein  which prevent the lungs 
from collapsing, are often switched-off in lung cancer tumours.  The tumour is usually 
solid and has no need for the surfactant.  Hence repressed activity levels of these 
proteins is a possible indicator for that disease. 
 
Proteins are, of course, three-dimensional objects, and if two proteins are said to 
interact this means that they physically combine.  Experiments can now be conducted 
where, in principle, every possible pair of proteins in the cell can be tested to see if a 
mutual interaction takes place. The resulting PPI network is simply an undirected 
graph whose nodes are proteins and whose edges denote observed interactions 
[Grindrod04].   
 
In a simplified world where each protein has a single biological function and a protein 
always forms part of the same biological team, the principle of guilt-by-association 
can be effective. The biological function of a protein could be predicted by observing 
which other proteins had correlated expression levels, or which other proteins were 
neighbours in the PPI network, assuming that the function of those correlated proteins 
was known. However, the real story is rarely so clear-cut, with multiple sets of 
proteins able to perform similar tasks and with single proteins playing multiple roles. 
So, more flexible, unsupervised, methods are needed to identify the complex networks 
that maintain the systems biology of the cell. 
 
Section 3: How is the Data Produced?  
Microarrays depend on complimentary DNA and RNA molecules: this simply means 
that they form double helices with pairing rules  A matches with T and C with G. A 
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sequence of 25 nucleotides can be synthesized onto about 10
6
 to 10
8
 individual 
positions on an Affymetrix GeneChip© (http://www.affymetrix.com/index.affx), 
while longer pieces of DNA (60  100) can be attached to other glass microarrays 
[Hardiman04].  More unusually now, longer DNA fragments  grown in bacteria, are 
used in cDNA (copy DNA) microarrays.  However, despite production differences, all 
microarray devices depend on the specific sequence matching rules to ensure that only 
the required mRNA is detected by either one or several spots (Figure 2).  The mRNA 
being measured is first copied onto a molecule that has some tag, often fluorescent, 
incorporated  this is what is detected to give a numerical measure of the signal for 
each spot.  The signal has to be evaluated in various ways, depending on the physical 
design of the device. The casual user is advised to avoid this step and acquire 
normalised data, and also to be aware that each step in the preparation of 
microarray results contributes noise that can affect the reproducibility of the 
expression data. There are publicly available microarray repositories. Among the most 
accessible are the National Center for Biotechnology Information 
(www.ncbi.nlm.nih.gov/geo), the European Molecular Biology Laboratorys 
European Bioinformatics Institute (www.ebi.ac.uk/arrayexpress), and Stanford 
MicroArray Database (genome-www5.stanford.edu/) with associated publications and 
replication of published methods to identify clusters of genes or groups of samples 
that are useful first steps in beginning to analyse datasets.  
 
 
 
 
 
Figure 2: c DNA microarray (left) and Affymetrix GeneChip© (right); each gene 
represented by one or several spots. 
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To fix notation,  we will let the microarray data take the form of a real M×N matrix, 
W , where M is the number of genes (rows) and N is the number of samples 
(columns), with  measuring the activity (expression level) of gene i in sample 
j. The larger the value , the greater the activity level. 
0tijW
Wij
 
As noted in the previous section, it is also possible to analyse proteins directly and see 
which proteins can physically interact (bind or become attracted) with one another. 
Yeast two hybrid (Y2H) experiments allow biologists to measure, in a pair-wise 
fashion, whether proteins interact. The two hybrid system is based on the premise that 
many eukaryotic transcriptional activators consist of two physically discrete modular 
domains. The DNA binding domain of the transcription factor is expressed as a hybrid 
protein fused to protein X (the "bait"), the activation domain is fused to protein Y (the 
"prey"). The domains act as independent modules: neither alone can activate 
transcription. Only if proteins X and Y interact will the activation domain be in the 
proper position to activate transcription of the reporter gene. As with microarray data, 
PPI networks obtained this way are very noisy; experimental limitations are believed 
to result in at least 50% for both the false negative (missing interactions) and false 
positive (spurious interactions) rates [Grindrod02, Titz04]. In Figure 3 we plot the 
adjacency matrix of a PPI network for yeast based on the data in [Uetz2000]. Here, a 
dot in row i and column j indicates an interaction between proteins i and j. In this case 
there are 1048 proteins and 1029 interactions.  
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More accurate, but much less exhaustive, methods for discovering interactions are 
available, and the data from these can be used to post-process the network producing 
so-called high-confidence networks [Bader03] 
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Figure 3: Adjacency matrix for the yeast PPI network from [Uetz2000]. A dot 
indicates a nonzero. 
 
Notwithstanding the inherent uncertainty in the experimental data, we should also 
keep in mind that the yes or no, binary, nature of the PPI network is necessarily an 
oversimplification. Whether two proteins interact may depend on environmental 
conditions within the cell and, in particular, on the presence or absence of other 
proteins. Further, biological false positives may be recordedin this case, two 
proteins are observed to interact when brought together in the experimental procedure, 
 8
but will never have the opportunity to meet in the cell because they operate in distinct 
physical regions or exist at different times in the cells life cycle. 
 
In summary, our PPI data takes the form of a real symmetric N×N matrix, W, where N 
is the number of proteins, with 1 ijW  if proteins i and j are observed to interact and 
 if there is no interaction. 0 ijW
 
Section 4: What are the Questions? 
Microarray and PPI data sets provide large-scale, noisy, information. This must be 
distilled and refined if we are to draw biologically meaningful inferences. The 
overlapping fields of data mining, dimension reduction and machine learning provide 
tools for this purpose, and there are already many success stories [Grindrod06]. In this 
article we focus entirely on one toolspectral analysis, giving an intuitive, 
algorithmic derivation of this SVD-based approach. 
 
Typical questions that biologists and medics may ask of high-throughput genomic 
data include 
1) Can a disease be linked to a particular set of genes? (For example: Are genes 
A, B and C are almost exclusively overexpressed in patients with disease Y?)  
2)  Given a new tissue sample, can we accurately classify it as either normal or 
cancerous? 
3) Given that gene A is known to play an important role in some biological 
function, can we discover any other genes that behave similarly to gene A and 
hence may also be involved in this function? 
4) Can we assign the genes/samples to clusters, where members within each 
cluster have common behaviour? 
5) Similarly, can we divide proteins into strongly interconnected clusters? 
6) Following on from 4) and 5), can we order the genes/samples/proteins so that 
near-neighbours are highly similar/strongly connected and far-neighbours are 
very dissimilar/weakly connected? 
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These issues are clearly interrelated. We will motivate our SVD approach with the 
ordering problem, 6), although the resulting algorithm also addresses the clustering 
problem 4)-5) and can be used to tackle questions 1), 2) and 3). 
 
Section 5:  How does the SVD Come in? 
We now derive an algorithm, based on biological principles, to tackle the ordering 
question 6) discussed at the end of the previous section. It turns out that we recover 
the SVD for a rectangular matrix via the well-known power method to find the 
dominant eigenvalue of a square matrix. 
 
First, let us repeat the ordering question 6) for samples in a microarray experiment. 
Imagine that we are trying to find an ordering of the samples on the real line such that 
close samples exhibit similar gene expression levels, whereas samples far apart on the 
real line show very different gene expression levels. In order to implement this 
reordering, our first task is to find a measure with which to compare samples. 
 
As discussed in Section 2, given M genes and N samples the gene expression values 
of the samples are stored in an M×N rectangular array W. We have in mind the case M 
> N (many genes and few samples) though, in fact, our ideas and analysis hold 
equally well for M  N. We shall take as similarity measures the elements in the N×N 
matrix . Mathematically, for 1  i, j  N, the ijth element of  is WW T WW T
  .)()()(
11
¦¦
  
  
M
l
ljli
M
l
ljil
T
ij
T WWWWWW
 
Biologically, Wli Wlj denotes the product of the expression levels of gene l in samples 
i and j. So if we sum over all the genes, that is, over l = 1,,M, we obtain a measure 
of the total gene expression level for all genes that are expressed in both sample i and 
sample j. We expect this value to be large when sample i is closely related to sample j, 
but small if the samples are unrelated. (Note that all the elements of W are assumed to 
be non-negative so no cancellation occurs in summing Wli Wlj.) 
 
For convenience we write 
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  WWA T 
and assume that A has row and column sums equal to 1, that is, for row i and column 
j, 
  (1) .1       ,1
11
  ¦¦
  
N
t
tj
N
t
it aa
(This assumption makes the following discussion easier, but it is not essential. If the 
matrix A does not have this property a simple rescaling, often called normalization, 
can be implemented, see, for example, [Higham05, Knight06].) We also note that the 
derivation below applies equally well to the case where proteins are to be ordered 
from PPI data. In this case we would deal directly with the (symmetric) matrix W,  
rather than . WW T
 
Based on the data, our aim now is to assign a real value to each sample in such a way 
that the ordering of these values reflects a useful ordering of the samples. We start 
with some initial, arbitrary, set of values and proceed iteratively. Denote the initial 
position on the real line of the ith sample as . We seek an iterative algorithm to 
reposition the ith sample based on its relationship with all other samples. We claim 
that a reasonable candidate for repositioning is  
]0[
ix
   (2) ¦
 
  
N
t
k
tit
k
i xax
1
][]1[
for k=0,1,2,, with k counting the number of iterations. In (2), the idea is that the 
new position of the ith sample is a weighted combination of the current position of all 
samples, with the weight for the tth sample depending on how closely samples i and t 
are related. 
 
However, there is a redundancy in (2), in that all the  could be shifted by an 
arbitrary amount, s say, with no change in the ordering, as is seen from 
][k
ix
 3) sxasxasxa ki
N
t
it
N
t
k
tit
N
t
k
tit    
   
¦¦¦ ]1[
11
][
1
][ )(  (
using (1). 
 
To remove this redundancy, let us make a shift so that the mean position of the genes 
is centered at 0. This is implemented as 
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that is, we subtract the mean of the  values. Hence ][kix
 , 0
1 1
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using (1). In fact, if the initial ordering has zero mean, that is,  
 0 , (5) 
1
]0[  ¦
 
N
t
tx
then (4) and (2) coincide, ensuring that all future orderings have zero mean, and the 
freedom expressed by (3) is removed. In practice, round-off errors in evaluating the 
sums in (4) would cause the mean to drift away from zero, so (4) is less prone to 
numerical instabilities.  
 
In matrix-vector notation, (4) may be written as 
 
][1][k
1 1
1 kT
x
N
Ax ¹¸
·
©¨
§    (6) 
where 
][k
x is the vector whose i
th
 component gives the position of the i
th
 sample at the 
k
th
 iteration. Here, T)1,...,1,1( 1 , and the outer product T1 1  is the N×N matrix with 
each component equal to 1. 
 
We now make the simple observation that (6) is the well known power method, and 
hence our iterates will converge to an eigenvector [Golub&VanLoan96]. Some 
straightforward linear algebra now allows us identify this vector and tie it to the SVD.  
 
Because  is a positive semidefinite matrix with non-negative elements, the 
classical Perron-Frobenius Theorem says that there is an eigenvalue at the spectral 
radius, and the corresponding eigenvector has strictly positive components 
[Horn&Johnson85]. Since 
WWA T 
1
1
 d AxxA OO , from (1), we know that the 
spectral radius of A is less than or equal to 1. But, by construction, 11  A , so 1 O  is 
the dominant eigenvalue of A with corresponding eigenvector 1. In the generic case 
where A is irreducible (see, for example, [Horn&Johnson85, p. 361]), this eigenvalue 
is simple, and the iteration (6) is precisely the power method applied to the matrix 
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¹¸
·
©¨
§  T
N
A 1 1
1
 with a starting vector satisfying 01
]0[  xT  (from (5)). We see that the 
matrix A has been deflated, with the dominant eigenvalue being mapped to zero. 
Hence the iterates will converge to the eigenvector corresponding to the subdominant 
eigenvalue (assumed to be simple). In other words, (6) performs a power method 
iteration that generically converges to a vector corresponding to the second largest 
eigenvalue of A. 
 
Finally, we arrive at the SVD. Since , that subdominant eigenvalue of A is 
the square of the second largest singular value of W, and the converged eigenvector 
from (6) is the corresponding right singular vector of W.  
WWA T 
 
In summary, the ordering arising from (2) with (5), which was motivated by seeking 
similarities between samples on the basis of connections to genes, yields precisely the 
second right singular vector of W.  In practice, we need not implement the iteration 
given by (6). Instead, we could use standard software to compute the second right 
singular vector of W, directly obtaining the desired ordering of the samples. Similarly, 
an algorithm to order genes can be derived as above, but using WW
T
, producing an 
ordering based on that given by the second left singular vector of W. Numerical 
results to show the effectiveness of these ideas are given in the next section. 
 
It is often the case that other re-arrangements of the samples or genes are also 
relevant, and arguments along the lines of those above can be used to show that the 
third, fourth, etc. left and right singular vectors are natural candidates. One way to 
justify this generalisation is developed in [Higham07a], and illustrations also appear 
in the next section. 
  
Section 6: Does it Work? 
To illustrate the performance of the SVD, we give some results on microarray data 
from cancer studies. Here, each sample (corresponding to each column of W) is from 
the tumour of a patient with a known type of cancer, or from a normal/control tissue. 
In these examples, we are simply testing whether the SVD can rediscover the known 
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groupings, but it should be clear that a successful algorithm has enormous potential 
for revealing new information and answering questions like those listed at start of 
section 3. 
 
 
 
 
Figure 4: Upper left: carcinoma (stars) and normal (circles) liver samples; here 
M=12065 and N=152. Upper right: T (triangles) and B (circles) cell ALLs, AML 
(stars); here M=7129 and N=72. Lower left: normal in vivo (squares) and in vitro 
(circles) and carcinomas in vivo (triangles) and in vitro (stars); here M=20428 and 
N=21. Lower right: carcinoma (stars) and normal (circles) lung samples; here 
M=5983 and N=34. 
Figure 4 gives the results. In each of the four cases we have used both the second and 
third right singular vectors to give two-dimensional components for the samples, 
producing a scatter plot where nearby samples are likely to be related. Let us re-
emphasize that the underlying idea here is to use correlation in gene expression 
behaviour in order to classify sample types. In the upper left scatter plot clear 
separation of the carcinoma (stars) and normal (circles) kidney samples has been 
achieved by the second singular vector in data from [Choi05]. The upper right part of 
Figure 4 shows a scatter plot of the second versus third singular vectors of 72 
leukaemia samples from [Golub99]. In this plot the samples are known to divide into 
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three different groups. We see that the second singular vector does a good job of 
separating the ALLs and AMLs, while the third singular vector focuses on 
distinguishing between the T and B subtypes of ALL. Four clear subgroups can be 
seen in the lower left part of the Figure 4. The second, dominant, singular vector 
separates in vivo and in vitro samples and the third vector divides normal samples 
from oral carcinomas. This data comes from the first set of experiments of an ongoing 
study led by Dr. Johanna K. Thurlow at the Beatson Institute for Cancer Research, 
Glasgow. Microarray analysis of normal oral cultures or biopsies and immortal 
carcinomas grown in vivo (xenografts/human tumour) or in culture (in vitro) has 
defined a carcinoma gene expression signature which is maintained in vivo and in 
vitro. Finally, in the lower right of the figure we can see a scatter plot of two 
dominant vectors for a set of lung carcinomas and normal lung samples [Choi05]. 
Although a good separation can be deduced from this plot, it is not performed by a 
single singular vector. This is an example where carcinomas and normal samples can 
be distinguished only by using a combination of singular vectors. Although singular 
value ı2, shown in Figure 5, left, is far apart from the rest of the singular values the 
corresponding singular vector alone does not produce clear separation.  We see that 
the next two singular values, ı3 and ı4, are also separated from the rest of the pack, 
and an appropriate 3D plot of the lung data set reveals the shapes of two clusters 
(Figure 5, right). 
 
Figure 5: Left: singular values ı2, ı3  Right: carcinoma (stars) and normal (circles) 
lung samples. 
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In Figure 6 we show how the PPI network from Figure 3 looks when it is reordered 
according to the first subdominant singular vector (also called the Fiedler vector in 
this context).  In linear algebra terms, we have applied a symmetric row/column 
permutation to the adjacency matrix. We see that the new ordering encourages 
nonzeros to lie close to the diagonal; proteins that appear close together in this new 
ordering are much more likely to interact than proteins that appear far apart, and the 
reordering shows that it is possible to view the network as being made up largely of 
local interactions with relatively few long-range links, as proposed in [Grindrod02]. 
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Figure 6: The adjacency matrix for the PPI network in Figure 3 when reordered 
using the subdominant singular vector (or Fiedler vector). 
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Section 6: What Else Can We Do? 
Even if we restrict ourselves to the topic of analysing genomic data sets from a 
computational matrix viewpoint, there are many exciting extensions and variations of 
the basic ideas presented here. For example, 
 
x Along with clustering/ordering information, it is possible to analyse 
sensitivity, giving information about how reliable the results are in the 
presence of uncertainty in the data [Spence07]. 
   
x The expression levels in microarray data can take the form of signed data, 
with negative values representing under-expression [Higham07b]. 
 
x Matrix-based inference algorithms can be developed through a systematic 
Bayesian approach [Lo&Gottardo07], and in the case where data represents 
evolution, algorithms for time series may be appropriate [Filkov02]. 
 
x As an alternative to the SVD, a Non-negative Matrix Factorization can be 
used [Fogel07]. 
 
x Expression data from two different organisms can be analysed with the 
Generalized Singular Value Decomposition [Alter03]. 
 
x Viewing the data as representing a network of interactions, random graph 
models can be developed [deSilva&Stumpf05] and used to extract 
biologically meaningful information [Morrison06]. 
 
x Generally, in order to add the most value, algorithms that work on multiple 
sources of data (including discrete quantities from, for example, sequence 
analysis or interaction and real-valued expression measurements)  must be 
developed [Li06]. 
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Overall, we hope to have convinced the reader that there is a range of important and 
exciting activities taking place at the data-driven end of computational cell biology 
where algorithms in matrix computation are being pushed to their limits in the 
analysis of large, noisy biological datasets. 
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